Abstract
The effects of intravenous (i.v.) or intracerebroventricular (i.c.v.) administration of γ aminobutyric acid (GABA) on plasma growth hormone (GH) concentrations have been examined in sheep. Intravenous administration of GABA resulted in a rapid, significant ( P<0.001) increase in plasma GH. Administration of 10 mg of GABA i.c.v. produced a significant ( P<0.001) increase in GH release. By contrast, 100 mg given i.c.v. was inhibitory and resulted in a decrease ( P<0.05) in plasma GH levels. Concurrent administration of somatostatin (0.5 μg/min i.v. over 1 h) did not alter the plasma GH response to 10 mg GABA given i.c.v. These data are consistent with the concept of dual sites of action for GABA in regulating GH release in sheep, but the exact mechanism through which this effect is mediated remains unclear.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
